Product
CITI-002
1 clinical trial
1 indication
Indication
HemorrhoidsClinical trial
A Randomized, Dose-Ranging, Double Blind Study to Demonstrate the Safety and Efficacy of a CITI-002 Cream in the Seven Day Twice-Daily Treatment of Grade II or III HemorrhoidsStatus: Completed, Estimated PCD: 2023-04-20